Here are the biotech companies with exposure to experimental vaccines whose shares saw the biggest boost from this past week's coronavirus news.
Here are some biotech companies with exposure to experimental vaccines whose shares are seeing the biggest boost from the latest coronavirus news.
As with almost all pandemic scares and other national and global issues, some speculative stocks manage to see their shares rise sharply.
The Wuhan Coronavirus has escaped China, with the number of cases and the death toll rising. The economic impact beyond the loss of life and suffering is real in many stocks, sectors…
The Wuhan Coronavirus has already left China and hit neighboring countries, the U.S. and even in Europe in Australia. As the death toll and number of infected are rising each hour, the…
New research shows that several members of the coronavirus family are susceptible to inactivation via a system developed by biomedical products company Cerus.
China is facing an outbreak of the coronavirus, which may have spread to a few other countries in Asia. As a result, experimental vaccine stocks are skyrocketing.
An FDA nod for NanoFlu, a recombinant quadrivalent seasonal influenza vaccine candidate, offered a boost to Novavax shares on Wednesday.
Chris Lange Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff.
Judging by the most shorted stocks traded on the Nasdaq between the February 15 and February 28 settlement dates, those sellers were focused on a couple of their favorites.
Judging by the most shorted stocks traded on the Nasdaq between the January 31 and February 15 settlement dates, those sellers were stocking up on some of their favorites.
Judging by the most shorted stocks traded on the Nasdaq between the January 15 and January 31 settlement dates, those sellers were focused on a few favorites.
Judging by the most shorted stocks traded on the Nasdaq between the December 31 and January 15 settlement dates, those sellers were still accumulating some of their favorites.
Judging by the most shorted stocks traded on the Nasdaq between the December 14 and December 31 settlement dates, those sellers were focused on a few of their favorites.
Novavax shares jumped early on Friday after the company reported that its midstage flu vaccine had some positive results.
Chris Lange 
